Abstract
Purpose
The aim of this review is to assess the extent of the use of off-label and/or unlicenced drugs among hospitalised children.
Methods
A systematic search was made in MEDLINE-PubMED for papers published from 1994 to 2012, addressing the prescription of off-label and/or unlicenced drugs for the paediatric population in hospital care.
Results
Of the 829 studies retrieved, 34 met the inclusion criteria. Prescriptions ranged from 12.2 to 70.6 % for off-label and from 0.2 to 47.9 % for unlicensed drugs. The percentage of children who received at least one off-label and/or unlicensed drug ranged from 42.0 to 100 %, with newborns being the population that received most of such drugs. Off-label prescriptions were essential for dose modification (7.1–73.1 %) and unlicensed prescriptions for formulation modification purposes (3.6–100 %).
Conclusions
These findings show that: (i) off-label and/or an unlicensed prescribing is widespread among the hospitalised paediatric population worldwide, (ii) there is no consensus on a definition of off-label and/or unlicensed drugs and (iii) preterm newborns receive most off-label and/or unlicensed drugs. By shedding new light on off-label and/or unlicensed drug prescribing, these findings will hopefully contribute to generating new, more effective knowledge about the paediatric population’s need for quality drugs that are both safe and efficacious.
Similar content being viewed by others
References
Official Journal of the European Union, Brussels. EC (2006) Regulation (EC) N0 1901/2006 of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004.
Kimland E, Odlind V (2012) Off-label drug use in pediatric patients. Clin Pharmacol Ther 91(5):796–801
Yewale VN, Dharmapalan D (2012) Promoting appropriate use of drugs in children. Int J Pediatr 2012:906570
Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF et al (2007) Stimulation programs for pediatric drug research—do children really benefit? Eur J Pediatr 166(8):849–855
Lass J, Naelapää K, Shah U, Käär R, Varendi H, Turner MA et al (2012) Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr 12:136
Kumar P, Walker JK, Hurt KM, Bennett KM, Grosshans N, Fotis MA (2008) Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr 152(3):412–415
Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164(9):552–558
Rocchi F, Paolucci P, Ceci A, Rossi P (2010) The European paediatric legislation: benefits and perspectives. Ital J Pediatr 36:56
Ceci A, Felisi M, Baiardi P, Bonifazi F, Catapano M, Giaquinto C et al (2006) Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years. Eur J Clin Pharmacol 62(11):947–952
Posthumus AAG, Alingh CCW, Zwaan CCM, van Grootheest KK, Hanff LLM, Witjes BBCM et al (2012) Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open 2(4):e000934
Haffner S, Von Laue N, Wirth S, Thürmann PA (2005) Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Saf 28(5):453–464
Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52(1):77–83
Schirm E, Tobi H, Van Puijenbroek EP, Monster-Simons MH, Van den berg DeJong LTW (2004) Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiol Drug Saf 13(3):159–165
Ufer M, Kimland E, Bergman U (2004) Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 13(3):147–152
Horen B, Montastruc J-L, Lapeyre-mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54(6):665–670
Turner S, Nunn AJ, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88(9):965–968
ICH Topic E 11 Clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). European Medicines Agency; 2001.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo; 2012.
Turner S, Longworth A, Nunn AJ, Choonara I (1998) Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 316(7128):343–345
Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 1999 Mar;80(2):F142–144; discussion F144–145.
Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320(7227):79–82
t Jong GW, Vulto AG, De Hoog M, Schimmel KJ, Tibboel D, Van den Anker JN (2001) A survey of the use of off-label and unlicensed drugs in a Dutch children’s hospital. Pediatrics 108(5):1089–1093
Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M et al (2002) Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 91(3):339–347
Barr J, Brenner-Zada G, Heiman E, Pareth G, Bulkowstein M, Greenberg R et al (2002) Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 19(2):67–72
’t Jong GW, Van der Linden PD, Bakker EM, Van der Lely N, Eland IA, Stricker BHC et al (2002) Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 58(4):293–297
O’Donnell CPF, Stone RJ, Morley CJ (2002) Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 110(5):e52–e52
Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA (2003) Identificação de medicamentos ‘não apropriados para crianças” em prescrições de unidade de tratamento intensivo pediátrica. J Pediatr 79:397–402
López Martínez R, Cabañas Poy MJ, Oliveras Arenas M, Clemente BS (2005) Utilización de medicamentos en una UCI neonatal: estudio prospectivo. Farm Hosp 29(1):26–29
Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R et al (2005) Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol 61(10):775–779
Di Paolo E, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M et al (2006) Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly 136(13–14):218–222
Eiland LS, Knight P (2006) Evaluating the off-label use of medications in children. Am J Health Syst Pharm 63(11):1062–1065
Dell’Aera M, Gasbarro A, Padovano M, Laforgia N, Capodiferro D, Solarino B et al (2007) Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 29(4):361–367
Jain S, Bavdekar SB, Gogtay N, Sadawarte P (2008) Off-label drug use in children. Indian J Pediatr 75(11):1133–1136
Santos D, Clavenna A, Bonati M, Coelho H (2008) Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol 64(11):1111–1118
Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H (2009) Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 34(3):277–287
Bavdekar SB, Sadawarte P, Gogtay N, Jain S, Jadhav S (2009) Off-label drug use in a pediatric intensive care unit. Indian J Pediatr 76(11):1113–1118
Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W (2010) Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol 66(1):87–95
Morales-Carpi C, Estañ L, Rubio E, Lurbe E, Morales-Olivas F (2010) Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol 66(3):315–320
Dessì A, Salemi C, Fanos V, Cuzzolin L (2010) Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci 32(2):120–124
Doherty D, Pascuet E, Ni A, Stewart P, Splinter W, Vaillancourt R (2010) Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies. Can J Anesth 57(12):1078–1088
Nguyen K-A, Claris O, Kassai B (2011) Unlicensed and off-label drug use in a neonatal unit in France. Acta Paediatr 100(4):615–617
Khdour M, Hallak H, Alayasa K, AlShahed Q, Hawwa A, McElnay J (2011) Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm 33(4):650–655
Van den Berg H, Tak N (2011) Licensing and labelling of drugs in a paediatric oncology ward. Br J Clin Pharmacol 72(3):474–481
Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I (2011) Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol 67(12):1263–1271
de Ferreira L, da Ibiapina CC, Machado MGP, Fagundes EDT (2012) A alta prevalência de prescrições de medicamentos off-label e não licenciados em unidade de terapia intensiva pediátrica brasileira. Rev Assoc Med Bras 58:82–87
Oguz SS, Kanmaz HG, Dilmen U (2012) Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study. Int J Clin Pharm 34(1):136–141
Dos Santos L, Heineck I (2012) Drug utilization study in pediatric prescriptions of a university hospital in southern brazil: off-label, unlicensed and high-alert medications. Farm Hosp 36(4):180–186
Palčevski G, Skočibušić N, Vlahović-Palčevski V (2012) Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey. Eur J Clin Pharmacol 68(7):1073–1077
Kimland E, Nydert P, Odlind V, Böttiger Y, Lindemalm S (2012) Paediatric drug use with focus on off-label prescriptions at Swedish hospitals—a nationwide study. Acta Paediatr 101(7):772–778
Carvalho CG, Ribeiro MR, Bonilha MM, Fernandes M Jr, Procianoy RS, Silveira RC (2012) Uso de medicamentos off-label e não licenciados em unidade de tratamento intensivo neonatal e sua associação com escores de gravidade. J Pediatr 88:465–470
Ballard CD, Peterson GM, Thompson AJ, Beggs SA (2013) Off-label use of medicines in paediatric inpatients at an Australian teaching hospital. J Paediatr Child Health 49(1):38–42
Maltz LA, Klugman D, Spaeder MC, Wessel DL (2013) Off-label drug use in a single-center pediatric cardiac intensive care unit. World J Pediatr Congenit Heart Surg 4(3):262–266
Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr et al (2007) Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med 161(3):282–290
Hsu B, Brazelton T (2009) Off-label medication use in an academic hospital pediatric critical care unit. WMJ 108(7):343–348
Neubert A, Wong ICK, Bonifazi A, Catapano M, Felisi M, Baiardi P et al (2008) Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res 58(5–6):316–322
Choonara I, Conroy S (2002) Unlicensed and off-label drug use in children: implications for safety. Drug Saf 25(1):1–5
Rocchi F, Tomasi P (2011) The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacol Res 64(3):169–175
Baiardi P, Ceci A, Felisi M, Cantarutti L, Girotto S, Sturkenboom M et al (2010) In-label and off-label use of respiratory drugs in the Italian paediatric population. Acta Paediatr 99(4):544–549
Jong GW’t, Eland IA, Sturkenboom MCJM, Van den Anker JN, Stricker BHC (2004) Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J 23(2):310–313
Sen EF, Verhamme KMC, Neubert A, Hsia Y, Murray M, Felisi M et al (2011) Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr 170(1):81–92
Zanon D, Gallelli L, Rovere F, Paparazzo R, Maximova N, Lazzerini M et al (2013) Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy. Eur J Pediatr 172(3):361–367
Cuzzolin L, Zaccaron A, Fanos V (2003) Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 17(1):125–131
Conroy S (2002) Unlicensed and off-label drug use: issues and recommendations. Paediatr Drugs 4(6):353–359
European Union. Better medicines for children from concept to reality—PROGRESS REPORT ON THE PAEDIATRIC REGULATION (EC) N°1901/2006. 2013
Mukattash T, Hawwa AF, Trew K, McElnay JC (2011) Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol 67(5):449–461
Jonville-Béra AP, Béra F, Autret-Leca E (2005) Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol 61(3):231–236
Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W et al (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27(13):1059–1067
Milne C-P, Bruss JB (2008) The economics of pediatric formulation development for off-patent drugs. Clin Ther 30(11):2133–2145
Napoleone E (2010) Children and ADRs (adverse drug reactions). Ital J Pediatr 36:4
Acknowledgements
Author FR wish to thank to UDI/IPG and to the Foundation for Science and Technology (FCT) [Pest-OE/EGE/UI4056/2014], and author AF to the Health Research Fund (Fondo de Investigación Sanitaria) [PI12/02414 y PI081239].
Funding
None
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magalhães, J., Rodrigues, A.T., Roque, F. et al. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol 71, 1–13 (2015). https://doi.org/10.1007/s00228-014-1768-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1768-9